Medtronic (MDT) closed at $91.69, up 0.79% from the previous day, outperforming the S&P 500. The stock has risen by 13.9% in the past month, leading the Medical sector. Earnings report scheduled for February 18, 2025, with projected EPS of $1.36 and revenue of $8.33 billion.

Analysts anticipate positive estimate revisions for Medtronic, reflecting optimism about the company’s performance. The Zacks Rank system, with a current rating of #3 (Hold) for MDT, has historically shown strong stock price performance. Medtronic is trading at a Forward P/E ratio of 16.68, a discount compared to the industry average of 18.7.

Get in on potential home runs with 5 stocks set to double in 2024. Handpicked by Zacks experts, previous recommendations have soared up to +673.0%. These stocks are flying under Wall Street radar, offering a ground floor opportunity. Download 7 Best Stocks for the Next 30 Days for the latest recommendations from Zacks Investment Research.

Read more at Nasdaq: Medtronic (MDT) Laps the Stock Market: Here’s Why